Chronic cough, defined as a persistent cough lasting more than eight weeks, is a prevalent yet challenging condition to diagnose and manage. It can significantly impair patients' quality of life and often presents a diagnostic enigma to clinicians due to its multifactorial etiology.
Common causes include gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, the cough may also be a symptom of less common conditions like lung cancer or sarcoidosis. A thorough history and physical examination, supplemented by targeted investigations based on clinical suspicion, form the cornerstone of diagnosis.
Treatment of chronic cough is primarily aimed at addressing the underlying cause. Empirical treatment for the most common causes (GERD, UACS, and asthma) may be a pragmatic initial approach. However, refractory cases require a more comprehensive evaluation, including imaging studies and pulmonary function tests. In some cases, referral to a specialist may be necessary.
A multidisciplinary approach involving allergists, pulmonologists, gastroenterologists, and even speech-language pathologists can be beneficial in managing complex cases. This approach ensures comprehensive care, addressing not only the cough but also associated conditions like laryngeal hypersensitivity and swallowing disorders.
Emerging research on neuronal pathways and cough reflex sensitivity may yield novel therapeutic targets. In addition, the role of behavioral therapies in managing chronic cough is being increasingly recognized, opening new avenues for non-pharmacological interventions.
Chronic cough is a complex condition requiring a comprehensive and individualized approach to diagnosis and management. A thorough understanding of the etiological factors, coupled with a multidisciplinary approach, can significantly improve patient outcomes. Future research holds promise for more effective and targeted treatments.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation